T C T M van der Pouw Kraan
Overview
Explore the profile of T C T M van der Pouw Kraan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
432
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klaver E, van der Pouw Kraan T, Laan L, Kringel H, Cummings R, Bouma G, et al.
Genes Immun
. 2015 May;
16(6):378-87.
PMID: 25996526
Inflammatory immune disorders such as inflammatory bowel disease and multiple sclerosis are major health problems. Currently, the intestinal whipworm Trichuris suis is being explored in clinical trials to reduce inflammation...
2.
Ottow M, Klaver E, van der Pouw Kraan T, Heijnen P, Laan L, Kringel H, et al.
Genes Immun
. 2014 Jul;
15(7):477-86.
PMID: 25008860
Recent clinical trials in patients with inflammatory diseases like multiple sclerosis (MS) or inflammatory bowel disease (IBD) have shown the beneficial effects of probiotic helminth administration, although the underlying mechanism...
3.
van der Pouw Kraan T, Laan A, Piek J, Horrevoets A
Vascul Pharmacol
. 2012 Mar;
56(5-6):297-305.
PMID: 22387744
In this review we compare expression studies on monocyte subsets as an example to show the integrated possibilities of molecular databases and bioinformatic analysis tools. Monocytes have been recognized as...
4.
Vosslamber S, van der Voort L, van den Elskamp I, Heijmans R, Aubin C, Uitdehaag B, et al.
Genes Immun
. 2011 Apr;
12(6):466-72.
PMID: 21471993
Interferon-β (IFNβ) therapy is effective in approximately half of the patients with relapsing-remitting multiple sclerosis (RRMS). Clinical non-responders were characterized by an increased expression of IFN response genes before the...
5.
van Baarsen L, Wijbrandts C, Gerlag D, Rustenburg F, van der Pouw Kraan T, Dijkmans B, et al.
Genes Immun
. 2010 Jun;
11(8):622-9.
PMID: 20555356
To provide insight into the pharmacological changes in the peripheral blood (PB) molecular profile induced by tumor necrosis factor (TNF)-blockade in patients with rheumatoid arthritis (RA), blood was obtained in...
6.
Bos C, van Baarsen L, Timmer T, Overbeek M, Basoski N, Rustenburg F, et al.
Genes Immun
. 2009 Jan;
10(3):210-8.
PMID: 19129850
The objective of this study was to identify molecular profiles that may distinguish clinical subtypes in systemic sclerosis (SSc). Large-scale gene expression profiling was performed on peripheral blood (PB) from...
7.
van der Pouw Kraan T, van Baarsen L, Wijbrandts C, Voskuyl A, Rustenburg F, Baggen J, et al.
Genes Immun
. 2007 Oct;
9(1):16-22.
PMID: 17928867
Rheumatoid arthritis (RA) is a heterogeneous disease with unknown etiology. Here we aimed to distinguish RA subtypes based on peripheral blood (PB) gene expression profiles in comparison with a pathogen-response...
8.
van der Pouw Kraan T, Wijbrandts C, van Baarsen L, Voskuyl A, Rustenburg F, Baggen J, et al.
Ann Rheum Dis
. 2007 Jan;
66(8):1008-14.
PMID: 17223656
Background: Rheumatoid arthritis (RA) is a heterogeneous disease with unknown cause. Aim: To identify peripheral blood (PB) gene expression profiles that may distinguish RA subtypes. Methods: Large-scale expression profiling by...
9.
van Baarsen L, van der Pouw Kraan T, Kragt J, Baggen J, Rustenburg F, Hooper T, et al.
Genes Immun
. 2006 Jul;
7(6):522-31.
PMID: 16837931
Given the heterogeneous nature of multiple sclerosis (MS), we applied DNA microarray technology to determine whether variability is reflected in peripheral blood (PB) cells. In this study, we studied whole-blood...
10.
van Rietschoten J, Westland R, van den Bogaard R, Nieste-Otter M, van Veen A, Jonkers R, et al.
Tissue Antigens
. 2004 May;
63(6):538-46.
PMID: 15140029
Interleukin-12 (IL-12) is a potent inducer of interferon-gamma production by T cells and is a major factor for the development of T-helper 1 (Th1) cells. It exerts its biological effects...